Bayer shares rose as much as 15% on Tuesday after the U.S. solicitor general backed the company’s bid to get the Supreme ...

The biotech giant is facing over 67,000 US lawsuits over allegations that its Roundup weedkiller causes cancer — a claim ...

The company said the government’s support would be significant and could help limit tens of thousands of lawsuits.

In a brief filed with the Court, U.S. Solicitor General D. John Sauer supported Bayer’s view that federal law blocks ...

The company is facing more than 67,000 such lawsuits in US state and federal courts Read more at The Business Times.

European stocks traded in mixed territory on Tuesday, with shares struggling to find momentum after a broad sell-off marked ...

The Trump administration has thrown its support behind Bayer as the company urges the U.S. Supreme Court to review thousands of lawsuits alleging its Roundup weedkiller causes cancer. In a filing ...

Bayer’s stock surged on Tuesday after the U.S. Solicitor General supported the seed and pesticide company's push for the Supreme Court to review its Roundup weedkiller case. Th ...

The leaders said the company’s collaborative culture keeps patient benefit at the center of decision-making. To learn more about how Bayer’s model is transforming its pipeline, listen to the full ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.

Asundexian's Phase 3 study results raise hopes for a new class of cardiovascular drugs that has seen clinical setbacks.

Bayer is deploying GenAI tools at scale while many corporates struggle to find ROI on AI. The difference may lie in a 12-year ...